G Sridhar Prasad

G Sridhar Prasad is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceuticals. With a portfolio of three granted patents, he is focused on innovative solutions to combat metabolic disorders, particularly diabetes.

Latest Patents

One of G Sridhar Prasad's most notable inventions involves the development of novel compounds that function as activators of glucokinase. The present invention details compounds represented by Formulas I and II, as well as pharmaceutically acceptable salts and co-crystals, which exhibit glucokinase activator activity. These compounds have potential applications in pharmaceutical compositions aimed at treating, preventing, or delaying the onset of diseases associated with glucokinase, including Type 1 and Type 2 diabetes, impaired glucose tolerance, insulin resistance, and hyperglycemia. Furthermore, the invention includes methods for synthesizing these compounds and the related pharmaceutical compositions.

Career Highlights

G Sridhar Prasad currently holds a key position at Metabasis Therapeutics, Inc., where he continues to pursue groundbreaking research and development in the pharmaceutical industry. His expertise in the field has led to innovative solutions that address pressing health challenges.

Collaborations

Throughout his career, G Sridhar Prasad has collaborated with notable peers, including Feng Tian and Qun Dang. These partnerships have fostered an environment of shared knowledge and innovation, significantly enhancing the quality and impact of their research efforts.

Conclusion

G Sridhar Prasad stands out as a visionary inventor whose work is paving the way for advanced treatment options in metabolic health. His dedication to research and innovation not only contributes to the scientific community but also holds the promise of improving the lives of many affected by diabetes and related conditions.

Profile summary based on public USPTO records.